Business Segments · Selling, general, and administrative expense
Diabetes — Selling, general, and administrative expense
Medtronic Diabetes — Selling, general, and administrative expense increased by 7.5% to $300.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.8%, from $266.00M to $300.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026
Rolls up toSG&A
How to read this metric
A decrease relative to sales suggests improved operating leverage, while an increase may indicate higher investment in sales force expansion.
Detailed definition
This includes the costs of sales force compensation, marketing, legal, and administrative support functions dedicated to...
Peer comparison
Standard SG&A expense metric used across all industries for business segments.
Metric ID:
mdt_segment_diabetes_selling_general_and_administrative_expenseHistorical Data
11 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $176.25M | $176.25M | $176.25M | $176.25M | $259.00M | $266.00M | $266.00M | $287.00M | $274.00M | $279.00M | $300.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +47.0% | +2.7% | +0.0% | +7.9% | -4.5% | +1.8% | +7.5% |
| YoY Change | — | — | — | — | +47.0% | +50.9% | — | — | +5.8% | +4.9% | +12.8% |
Range$176.25M – $300.00M
CAGR+23.7%
Avg YoY Growth+24.3%
Median YoY Growth+12.8%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's diabetes — selling, general, and administrative expense?
- Medtronic (MDT) reported diabetes — selling, general, and administrative expense of $300.00M in Q1 2026.
- How has Medtronic's diabetes — selling, general, and administrative expense changed year-over-year?
- Medtronic's diabetes — selling, general, and administrative expense increased by 12.8% year-over-year, from $266.00M to $300.00M.
- What does diabetes — selling, general, and administrative expense mean?
- The costs of selling, marketing, and managing the administrative side of the diabetes business.